Morpheus8 – Two Dermal Treatments in One
The loss of desired skin tone and collagen can be caused by many factors. Sun damage, genetics, and aging can all create visible cosmetic changes that leave our skin looking and feeling dull and without elasticity.
Microneedling treatments create tiny channels in the skin about 4mm deep. These channels increase collagen production on the skin as our body “heals” the grooves. Radiofrequency treatments, on the other hand, stimulate collagen growth under the skin with an external applicator.
While these two non-invasive treatments are proven safe and effective, they alone sometimes do not provide the expected results.
Morpheus8 combines the effectiveness of micro-needling and radiofrequency into a single treatment procedure. Radiofrequency is sent through the microneedles, stimulating collagen growth above and below the skin’s surface.
This may not solve all cosmetic conditions on the skin’s surface. However, the ease of treatment and recovery make Morpheus8 a great alternative to many other dermal treatment options. In 2 to 4 sessions over several weeks, the doctor and team of expert aestheticians will treat the targeted areas in less than an hour.
Collagen development begins immediately after each treatment, and full results appear within a few months. There are no restrictions to activities after each session, and makeup can be applied 1 to 2 days after treatments. To achieve the best results, it is best to avoid direct sun exposure and apply broad-spectrum sunscreen every day.
The combination of micro-needling and radiofrequency energy into an all-in-one treatment makes Morhpeus8 a great option for dermal rejuvenation. The team at Fante Eye and Face Centre in Denver, Broomfield, and Boulder, CO, is available to answer any questions you may have and to discuss your aesthetic goals.
If you want to learn more about Morpheus8 or to get started on achieving your aesthetic goals, contact Fant Eye and Face Centre in the Denver, CO area at 303-839-1616, or visit www.drfante.com, today.